AVXL
Anavex Life Sciences Corp. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -15.4% ·
aandelenstroom -0.6% ·
netto nieuwe posities -18.2%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 80 | -1 | 31.52M | $81.72M | +7 | −8 |
| Q1 2026 | 83 | +4 | 34.46M | $105.82M | +13 | −9 |
| Q4 2025 | 79 | +2 | 31.53M | $112.26M | +2 | — |
| Q3 2025 | 14 | 0 | 20.35M | $181.11M | — | — |
| Q2 2025 | 11 | -2 | 18.83M | $173.63M | — | −2 |
| Q1 2025 | 10 | -1 | 6.83M | $58.56M | — | −1 |
| Q4 2024 | 11 | +3 | 6.21M | $66.68M | +3 | — |
| Q3 2024 | 7 | -2 | 3.52M | $20.02M | — | −2 |
| Q2 2024 | 9 | — | 3.99M | $16.85M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 7.00M | — | $64.56M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 7.00M | — | $64.56M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 7.00M | — | $64.56M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 7.00M | — | $64.56M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 7.00M | — | $64.56M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 7.00M | — | $64.56M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 7.00M | — | $64.56M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 7.00M | — | $64.56M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 7.00M | — | $64.56M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 7.00M | — | $64.56M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 7.00M | — | $64.56M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | The Vanguard Group ✦ (passief) | 5.11M | — | $47.09M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | The Vanguard Group ✦ (passief) | 5.11M | — | $47.09M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | The Vanguard Group ✦ (passief) | 5.11M | — | $47.09M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passief) | 5.11M | — | $47.09M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passief) | 5.11M | — | $47.09M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (passief) | 2.95M | -8.3% | $27.19M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Geode Capital Management ✦ (passief) | 2.02M | +2.8% | $18.62M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 19 | Geode Capital Management ✦ (passief) | 2.02M | +2.8% | $18.62M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 973.27K | +13.2% | $8.97M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 322.20K | +67875.7% | $2.97M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | Wellington Management ✦ | 194.92K | +4.2% | $1.80M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | Wellington Management ✦ | 194.92K | +4.2% | $1.80M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 24 | Wellington Management ✦ | 194.92K | +4.2% | $1.80M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 25 | Marshall Wace ✦ | 182.19K | 0.0% | $1.68M | 0.0% | Held | 3 | SEC ↗ |
| 26 | Marshall Wace ✦ | 182.19K | 0.0% | $1.68M | 0.0% | Held | 3 | SEC ↗ |
| 27 | T. Rowe Price ✦ | 41.77K | +26.4% | $386,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 29.06K | -0.3% | $267,958 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 29.06K | -0.3% | $267,958 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 29.06K | -0.3% | $267,958 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 31 | Fidelity (FMR) ✦ | 10.41K | — | $95,984 | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Fidelity (FMR) ✦ | 10.41K | — | $95,984 | 0.0% | n/c | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Millennium Management | $2.92M | was 0.0% |
| Renaissance Technologies | $120,120 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 39.00K aandelen, $119 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.